Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Sonothrombolysis: an emerging modality for the treatment of acute ischemic and hemorrhagic stroke.

Literature DB >> 24323621

Sonothrombolysis: an emerging modality for the treatment of acute ischemic and hemorrhagic stroke.

Azita Soltani¹, Wayne M Clark, Douglas R Hansmann.

Abstract

To date, it is believed that rapid removal of impedances hindering normal blood circulation in the brain would salvage ischemic tissue. Hence, most treatment modalities undergoing clinical evaluation for treatment of stroke are focused on faster recanalization in acute ischemic stroke or faster hematoma mass reduction in hemorrhagic stroke. Therapeutic ultrasound is among the promising emerging modalities being clinically evaluated to meet this purpose. This review provides an overview of existing clinical data in evaluating sonothrombolysis applications in treatment of acute ischemic and hemorrhagic stroke. Furthermore, the present status of clinical evaluation of microbubbles as a potential adjuvant to this modality is reviewed.

Entities: Disease

Year: 2011 PMID： 24323621 DOI： 10.1007/s12975-011-0077-1

Source DB: PubMed Journal: Transl Stroke Res ISSN： 1868-4483 Impact factor: 6.829

82 in total

1. Can a commercial diagnostic ultrasound device accelerate thrombolysis? An in vitro skull model.

Authors: Stefan Pfaffenberger; Branka Devcic-Kuhar; Christian Kollmann; Stefan P Kastl; Christoph Kaun; Walter S Speidl; Thomas W Weiss; Svitlana Demyanets; Robert Ullrich; Heinz Sochor; Christian Wöber; Josef Zeitlhofer; Kurt Huber; Martin Gröschl; Ewald Benes; Gerald Maurer; Johann Wojta; Michael Gottsauner-Wolf
Journal: Stroke Date: 2004-12-09 Impact factor: 7.914

2. High rate of recanalization of middle cerebral artery occlusion during 2-MHz transcranial color-coded Doppler continuous monitoring without thrombolytic drug.

Authors: Pascal Cintas; Anne Pavy Le Traon; Vincent Larrue
Journal: Stroke Date: 2002-02 Impact factor: 7.914

3. Insufficient and absent acoustic temporal bone window: potential and limitations of transcranial contrast-enhanced color-coded sonography and contrast-enhanced power-based sonography.

Authors: T Postert; J Federlein; H Przuntek; T Büttner
Journal: Ultrasound Med Biol Date: 1997 Impact factor: 2.998

4. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.

Authors: Lewis B Morgenstern; J Claude Hemphill; Craig Anderson; Kyra Becker; Joseph P Broderick; E Sander Connolly; Steven M Greenberg; James N Huang; R Loch MacDonald; Steven R Messé; Pamela H Mitchell; Magdy Selim; Rafael J Tamargo
Journal: Stroke Date: 2010-07-22 Impact factor: 7.914

5. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.

Authors: Werner Hacke; Greg Albers; Yasir Al-Rawi; Julien Bogousslavsky; Antonio Davalos; Michael Eliasziw; Michael Fischer; Anthony Furlan; Markku Kaste; Kennedy R Lees; Mariola Soehngen; Steven Warach
Journal: Stroke Date: 2004-11-29 Impact factor: 7.914

6. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline.

Authors: Larry B Goldstein; Robert Adams; Mark J Alberts; Lawrence J Appel; Lawrence M Brass; Cheryl D Bushnell; Antonio Culebras; Thomas J Degraba; Philip B Gorelick; John R Guyton; Robert G Hart; George Howard; Margaret Kelly-Hayes; J V Ian Nixon; Ralph L Sacco
Journal: Stroke Date: 2006-05-04 Impact factor: 7.914

7. Effectiveness and safety of transcranial laser therapy for acute ischemic stroke.

Authors: Justin A Zivin; Gregory W Albers; Natan Bornstein; Thomas Chippendale; Bjorn Dahlof; Thomas Devlin; Marc Fisher; Werner Hacke; William Holt; Sanja Ilic; Scott Kasner; Robert Lew; Marshall Nash; Julio Perez; Marilyn Rymer; Peter Schellinger; Dietmar Schneider; Stefan Schwab; Roland Veltkamp; Michael Walker; Jackson Streeter
Journal: Stroke Date: 2009-02-20 Impact factor: 7.914

8. Effect of ultrasound on thrombolysis of middle cerebral artery occlusion.

Authors: Jürgen Eggers; Björn Koch; Karsten Meyer; Inke König; Günter Seidel
Journal: Ann Neurol Date: 2003-06 Impact factor: 10.422

9. Preliminary report of the clot lysis evaluating accelerated resolution of intraventricular hemorrhage (CLEAR-IVH) clinical trial.

Authors: T Morgan; I Awad; P Keyl; K Lane; D Hanley
Journal: Acta Neurochir Suppl Date: 2008

Sonothrombolysis: an emerging modality for the treatment of acute ischemic and hemorrhagic stroke.

1. Can a commercial diagnostic ultrasound device accelerate thrombolysis? An in vitro skull model.

2. High rate of recanalization of middle cerebral artery occlusion during 2-MHz transcranial color-coded Doppler continuous monitoring without thrombolytic drug.

3. Insufficient and absent acoustic temporal bone window: potential and limitations of transcranial contrast-enhanced color-coded sonography and contrast-enhanced power-based sonography.

4. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.

5. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.

7. Effectiveness and safety of transcranial laser therapy for acute ischemic stroke.

8. Effect of ultrasound on thrombolysis of middle cerebral artery occlusion.

9. Preliminary report of the clot lysis evaluating accelerated resolution of intraventricular hemorrhage (CLEAR-IVH) clinical trial.

10. Treatment of basilar artery embolism with a mechanical extraction device: necessity of flow reversal.

1. Emerging Therapies: Pleiotropic Multi-target Drugs to Treat Stroke Victims.

Review 2. Neonatal brain hemorrhage (NBH) of prematurity: translational mechanisms of the vascular-neural network.

3. The efficacy of hyperbaric oxygen in hemorrhagic stroke: experimental and clinical implications.